Author | Avyakta Kallam, MD


Hope After Salvage Therapy Fails: Novel Agents for Relapsed/Refractory Hodgkin Lymphoma

May 14, 2019

ByAvyakta Kallam, MD|Julie M. Vose, MD, MBA

In this article, we present a case of a patient with relapsed Hodgkin lymphoma who responded to salvage chemotherapy incorporating brentuximab vedotin, a novel agent.